The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020

KELOWNA, BC, Oct. 14, 2020 /CNW/ – The Valens Company Inc.  (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to report its third quarter financial results for the period ended August 31, 2020. Key Financial Highlights Net revenue for the third quarter of 2020 was $18.1 million, aContinue reading “The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020”

The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2020

KELOWNA, BC, Oct. 6, 2020 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce it will issue its third quarter 2020 financial results, for the period ended August 31, 2020 on Wednesday, October 14, 2020, after markets close. CONFERENCE CALLContinue reading “The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2020”

The Valens Company and Verse Cannabis Roll Out Vape Cartridges, CBD Oil, and Hydrocarbon-Derived Crumble in Various Provinces

 – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced the rollout of various new products as part of a custom manufacturing agreement with Verse Cannabis (“Verse”), a group of innovators focused on bringing to market cutting-edge product formulationsContinue reading “The Valens Company and Verse Cannabis Roll Out Vape Cartridges, CBD Oil, and Hydrocarbon-Derived Crumble in Various Provinces”

The Valens Company Reports Financial Results for the Second Quarter of Fiscal 2020

– The Valens Company Inc.  (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to report its second quarter financial results for the period ended May 31, 2020. Key Financial Highlights of the Second Quarter of 2020 Revenue for the second quarter of 2020 was $17.6Continue reading “The Valens Company Reports Financial Results for the Second Quarter of Fiscal 2020”

The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart

 –The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced its participation in a Medical Cannabis Real-World Evidence Study (the “MC-RWE Study“) led by Dr. Hance Clarke of the University Health Network (UHN) in Toronto, Canada. The study will explore theContinue reading “The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart”

The Valens Company Signs Custom Manufacturing Agreement with Vancouver-Based FPS Brands to Launch ufeelu

 –Valens GroWorks Corp. (TSX: VLNS) (OTCQX: VLNCF)(“Valens” or “The Valens Company”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced it has signed a custom manufacturing agreement with Vancouver-based boutique brand house, FPS Brands Inc. (“FPS Brands”), to launch ufeelu, a line of craft, hemp-derived CBD products. Under the terms of the two-year agreement,Continue reading “The Valens Company Signs Custom Manufacturing Agreement with Vancouver-Based FPS Brands to Launch ufeelu”

The Valens Company and BRNT Launch Premium Vape Line “Made By” and Expand Custom Manufacturing Agreement

– Valens GroWorks Corp. (TSX: VLNS) (OTCQX: VLNCF) (“Valens” or “The Valens Company”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced the launch of a premium vape line, “Made By,” in partnership with BRNT Ltd. (“BRNT”), in addition to a strategic amendment to its existing custom manufacturing agreement with the leading, cannabis ancillaryContinue reading “The Valens Company and BRNT Launch Premium Vape Line “Made By” and Expand Custom Manufacturing Agreement”

The Valens Company Announces Custom Manufacturing Agreement with Next Generation Product Innovator, Verse Cannabis, To Launch Largest, Ultra Premium Concentrate Offering in Canada

Under the initial five-year agreement, The Valens Company will manufacture a range of innovative, new products, including hydrocarbon-derived crumble, one of first such entries into the Canadian legal market. Two initial product lines will be launched. First, the Verse Concentrates line will be introduced with crumble and an innovation-led product pipeline. The second line toContinue reading “The Valens Company Announces Custom Manufacturing Agreement with Next Generation Product Innovator, Verse Cannabis, To Launch Largest, Ultra Premium Concentrate Offering in Canada”